Le Lézard
Classified in: Health, Business
Subject: ERN

Sectra's Six-month Interim Report 2018/2019: Stronger Cash Flow and Increased Order Bookings in the US


LINKÖPING, Sweden, Dec. 7, 2018 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is growing in the medical IT and cybersecurity markets through collaboration with new and existing customers. Future ventures in new markets and new product areas are having a dampening effect on earnings but are expected to make a positive contribution to long-term growth. 

Six-month period, May?October 2018 

Second quarter in figures

Torbjörn Kronander, President and CEO of Sectra AB, comments 

"The order volume in the second quarter was favorable, but as expected did not reach the exceptional level reported in the corresponding quarter in the preceding year. The US operation doubled its order bookings and accounted for the largest increase during the period.

"The order book is healthy. All operating areas and geographic markets reported an increase in sales for the six-month period. Although the second quarter was slightly weaker than the comparative quarter, we are used to relatively large fluctuations between quarters and are well above our financial goals for the most recent 12-month period.

"Healthcare and cybersecurity are growing and rapidly changing markets, where numerous opportunities are being created for companies like Sectra. With stable underlying operations with favorable profitability and long-term customer contracts, we have laid a solid foundation for growth. Our high customer satisfaction, our fantastic employees?who make a difference in society and for their fellow human beings?and our exciting future initiatives will serve as the basis for our long-term success."

For further CEO comments and information, see the attached interim report.

Presentation of the interim report  

A teleconference will be held by Torbjörn Kronander, President and CEO of Sectra AB, and Mats Franzén, CFO of Sectra AB. The presentation will be held in English.

Time: December 7, 2018 at 10:00 a.m. (CET)

To participate, call:

SE +46856642662
UK +442030089808
US +18557532236

The report presentation can also be followed live online: www.sectra.com/irwebcast. A recorded version will also be available via this link after the conference.

This information constitutes information that Sectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and/or the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8:15 a.m. (CET) on December 7, 2018.

For further information, please contact: 

Torbjörn Kronander
President and CEO
Sectra AB
Tel +46-705-23-52-27

Press images: flickr.com/photos/sectramedicalsystems 

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/sectra/r/sectra-s-six-month-interim-report-2018-2019--stronger-cash-flow-and-increased-order-bookings-in-the-,c2693211

The following files are available for download:

https://mb.cision.com/Main/1263/2693211/959109.pdf

Sectra six-month report 2018/2019

http://news.cision.com/sectra/i/torbjorn-kronander--president-and-ceo-of-sectra-ab,c2541461

Torbjörn Kronander, President and CEO of Sectra AB

SOURCE Sectra


These press releases may also interest you

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...



News published on and distributed by: